The global ectoparasiticides market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by the increasing demand for ectoparasiticides in developing countries and the rising awareness about animal health among consumers in developed countries.
The global ectoparasiticides market is segmented on the basis of type, application, and region. On the basis of type, it is classified into permethrin, sulfur, lindane, benzyl benzoate (BB), ivermectin (IVM), and others (deltamethrin). Permethrin accounted for a major share in 2017 owing to its wide usage as an insecticide against ticks and mosquitoes that transmit diseases such as malaria or Zika virus respectively. Sulfur was also used extensively as an insecticide against flies that transmit diseases such as anthrax or tuberculosis respectively; however it has been banned in many countries due to its harmful effects on humans and animals alike. Lindane was used extensively for treating scabies but has been banned due to its carcinogenic properties; BB was used extensively for treating head lice but has been banned due to its carcinogenic properties; IVM was used extensively for treating roundworms but has been banned due to its carcinogenic properties; deltamethrin accounted for a major share owing to its wide usage as an insecticide against ticks that transmit diseases such as Lyme disease or Rocky Mountain spotted fever respectively. On the basis of application, it is classified into dogs & cats products (D&C), cattle products (C&P), pigs products (P&P), sheep & goats products (S&G) poultry products(P&O) and others(A). D&C accounted for a major share owing mainly because they are more susceptible than other animals like cattle or pigs which are less susceptible because they have thicker skin layers than dogs & cats do which makes them more resistant towards parasites like fleas or ticks respectively whereas P&O account only 1% because there are no ectoparaticides available specifically designed for poultry applications whereas A accounts only 2%. On the basis of region it includes North America(NA), Latin America(LA) Europe(EU) Asia Pacific(APAC) Middle East & Africa(MEA). NA accounts only 18% because there are no ectoparaticdes available specifically designed for North American applications whereas APAC accounts only 27% because China alone accounts over 50% followed by India with over 10%.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of diseases such as malaria and dengue fever has led to an increase in demand for these products in developing countries such as India and Brazil, which are witnessing rapid economic growth and urbanization trends that are driving up demand for these products.
- The growing number of travelers from regions with high incidence rates of malaria is also expected to drive growth in this market over the forecast period due to increased risk exposure among travelers visiting regions with high incidence rates of malaria or other ectoparasitic infections such as dengue fever or leishmaniasis among others and subsequent need for protection against them while traveling abroad or returning home after travel abroad especially when they have not been vaccinated against them before travel or if they have not received any preventive treatment before travel (e.g., chemoprophylaxis).
Industry Growth Insights published a new data on “Ectoparasiticides Market”. The research report is titled “Ectoparasiticides Market research by Types (Permethrin, Sulfur, Lindane, Benzyl Benzoate, Ivermectin, Others, ), By Applications (Dogs, Cats, Cattle, Pigs, Sheep and Goats, Poultry, Others, ), By Players/Companies Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Sanofi, Virbac, Vetoquinol, Dechra Pharmaceuticals, Advance Properties OOD/Huvepharma, Heranba, Tagros, Meghmani, Crop Life Science Limited, Aestar, Gharda, Guangdong Liwei, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ectoparasiticides Market Research Report
By Type
Permethrin, Sulfur, Lindane, Benzyl Benzoate, Ivermectin, Others,
By Application
Dogs, Cats, Cattle, Pigs, Sheep and Goats, Poultry, Others,
By Companies
Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Sanofi, Virbac, Vetoquinol, Dechra Pharmaceuticals, Advance Properties OOD/Huvepharma, Heranba, Tagros, Meghmani, Crop Life Science Limited, Aestar, Gharda, Guangdong Liwei,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Ectoparasiticides Market Report Segments:
The global Ectoparasiticides market is segmented on the basis of:
Types
Permethrin, Sulfur, Lindane, Benzyl Benzoate, Ivermectin, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Cattle, Pigs, Sheep and Goats, Poultry, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- MSD Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Eli Lilly and Company
- Zoetis
- Sanofi
- Virbac
- Vetoquinol
- Dechra Pharmaceuticals
- Advance Properties OOD/Huvepharma
- Heranba
- Tagros
- Meghmani
- Crop Life Science Limited
- Aestar
- Gharda
- Guangdong Liwei
Highlights of The Ectoparasiticides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Permethrin
- Sulfur
- Lindane
- Benzyl Benzoate
- Ivermectin
- Others
- By Application:
- Dogs
- Cats
- Cattle
- Pigs
- Sheep and Goats
- Poultry
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ectoparasiticides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ectoparasiticides are a type of pesticide that kill parasites.
Some of the key players operating in the ectoparasiticides market are Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Sanofi, Virbac, Vetoquinol, Dechra Pharmaceuticals, Advance Properties OOD/Huvepharma, Heranba, Tagros, Meghmani, Crop Life Science Limited, Aestar, Gharda, Guangdong Liwei.
The ectoparasiticides market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ectoparasiticides Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ectoparasiticides Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ectoparasiticides Market - Supply Chain
4.5. Global Ectoparasiticides Market Forecast
4.5.1. Ectoparasiticides Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ectoparasiticides Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ectoparasiticides Market Absolute $ Opportunity
5. Global Ectoparasiticides Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ectoparasiticides Market Size and Volume Forecast by Type
5.3.1. Permethrin
5.3.2. Sulfur
5.3.3. Lindane
5.3.4. Benzyl Benzoate
5.3.5. Ivermectin
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ectoparasiticides Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ectoparasiticides Market Size and Volume Forecast by Application
6.3.1. Dogs
6.3.2. Cats
6.3.3. Cattle
6.3.4. Pigs
6.3.5. Sheep and Goats
6.3.6. Poultry
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ectoparasiticides Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ectoparasiticides Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ectoparasiticides Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ectoparasiticides Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ectoparasiticides Demand Share Forecast, 2019-2026
9. North America Ectoparasiticides Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ectoparasiticides Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ectoparasiticides Market Size and Volume Forecast by Application
9.4.1. Dogs
9.4.2. Cats
9.4.3. Cattle
9.4.4. Pigs
9.4.5. Sheep and Goats
9.4.6. Poultry
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ectoparasiticides Market Size and Volume Forecast by Type
9.7.1. Permethrin
9.7.2. Sulfur
9.7.3. Lindane
9.7.4. Benzyl Benzoate
9.7.5. Ivermectin
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ectoparasiticides Demand Share Forecast, 2019-2026
10. Latin America Ectoparasiticides Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ectoparasiticides Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ectoparasiticides Market Size and Volume Forecast by Application
10.4.1. Dogs
10.4.2. Cats
10.4.3. Cattle
10.4.4. Pigs
10.4.5. Sheep and Goats
10.4.6. Poultry
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ectoparasiticides Market Size and Volume Forecast by Type
10.7.1. Permethrin
10.7.2. Sulfur
10.7.3. Lindane
10.7.4. Benzyl Benzoate
10.7.5. Ivermectin
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ectoparasiticides Demand Share Forecast, 2019-2026
11. Europe Ectoparasiticides Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ectoparasiticides Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ectoparasiticides Market Size and Volume Forecast by Application
11.4.1. Dogs
11.4.2. Cats
11.4.3. Cattle
11.4.4. Pigs
11.4.5. Sheep and Goats
11.4.6. Poultry
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ectoparasiticides Market Size and Volume Forecast by Type
11.7.1. Permethrin
11.7.2. Sulfur
11.7.3. Lindane
11.7.4. Benzyl Benzoate
11.7.5. Ivermectin
11.7.6.Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ectoparasiticides Demand Share, 2019-2026
12. Asia Pacific Ectoparasiticides Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ectoparasiticides Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ectoparasiticides Market Size and Volume Forecast by Application
12.4.1. Dogs
12.4.2. Cats
12.4.3. Cattle
12.4.4. Pigs
12.4.5. Sheep and Goats
12.4.6. Poultry
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ectoparasiticides Market Size and Volume Forecast by Type
12.7.1. Permethrin
12.7.2. Sulfur
12.7.3. Lindane
12.7.4. Benzyl Benzoate
12.7.5. Ivermectin
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ectoparasiticides Demand Share, 2019-2026
13. Middle East & Africa Ectoparasiticides Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ectoparasiticides Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ectoparasiticides Market Size and Volume Forecast by Application
13.4.1. Dogs
13.4.2. Cats
13.4.3. Cattle
13.4.4. Pigs
13.4.5. Sheep and Goats
13.4.6. Poultry
13.4.7. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ectoparasiticides Market Size and Volume Forecast by Type
13.7.1. Permethrin
13.7.2. Sulfur
13.7.3. Lindane
13.7.4. Benzyl Benzoate
13.7.5. Ivermectin
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ectoparasiticides Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ectoparasiticides Market: Market Share Analysis
14.2. Ectoparasiticides Distributors and Customers
14.3. Ectoparasiticides Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MSD Animal Health
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boehringer Ingelheim
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ceva Sante Animale
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eli Lilly and Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Zoetis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Virbac
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vetoquinol
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dechra Pharmaceuticals
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Advance Properties OOD/Huvepharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Heranba
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Tagros
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Meghmani
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Crop Life Science Limited
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Aestar
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Gharda
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Guangdong Liwei
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19.
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
